Article
The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Feb 2013
Levison Julie H, Wood Robin, Scott Callie A, Ciaranello Andrea L, Martinson Neil A, Rusu Corina, Losina Elena, Freedberg Kenneth A, Walensky Rochelle P
Abstract excerpt
BACKGROUND: In resource-limited settings, genotype testing at virologic failure on first-line antiretroviral therapy (ART) may identify patients with wild-type (WT) virus. After adherence counseling, these patients may safely and effectively continue first-line ART, thereby delaying more expensive second-line ART. METHODS: We used the Cost-Effectiveness of Preventing AIDS Complications International model of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
